| Product Name | Category | Characteristic & Application | CDMF status |
|---|---|---|---|
|
Zoledronic Acid
|
|
|
A
|
|
Gemcitabine HCL
|
|
|
A
|
|
Moxifloxacin HCL
|
|
|
A
|
|
Levetiracetam
|
|
|
A
|
|
Torasemide
|
|
|
A
|
|
Lurasidone HCL
|
|
|
A
|
|
Teriflunomide
|
|
|
A
|
|
Tadalafil
|
|
|
A
|
|
Celecoxib
|
|
|
A
|
|
Sildenafil Citrate
|
|
|
A
|
|
Dapagliflozin Propanediol Monohydrate
|
|
|
A
|
|
Abiraterone Acetate
|
|
|
A
|
|
Amisulpride
|
|
|
A
|
|
Brexpiprazole
|
|
|
I
|
|
Ivabradine HCL Amorphous
|
|
|
I
|
|
Donepezil HCL Monohydrate
|
|
|
I
|
|
Donepezil HCL Anhydrous
|
|
|
I
|
|
Topiramate
|
|
|
I
|
|
Temozolomide
|
|
|
I
|
|
Vortioxetine Hydrobromide
|
|
|
I
|
|
Posaconazole Form I
|
|
|
I
|
|
Crisaborole
|
|
|
I
|
|
Brivaracetam
|
|
|
I
|
|
Bilastine
|
|
|
I
|
|
Apremilast
|
|
|
I
|
|
Azilsartan Medoxomil Potassium
|
|
|
Plan to declare
|
|
Upadacitinib
|
|
|
Plan to declare
|
